Extremity osteosarcoma
Xem 1-1 trên 1 kết quả Extremity osteosarcoma
-
At present, no predictive factor has been validated for the early efficacy of neoadjuvant chemotherapy (NACT) in osteosarcoma. The purpose of this study was to investigate the significance of the neutrophil-to-lymphocyte ratio (NLR) in predicting the response to NACT in extremity osteosarcoma.
7p 
vielonmusk
21-01-2022
16
1
Download
CHỦ ĐỀ BẠN MUỐN TÌM
TOP DOWNLOAD
